No Data
No Data
SciSparc Ltd. Reports Changes in Financial Position
SciSparc | 6-K: Report of foreign private issuer (related to financial reporting)
SciSparc Ltd. Gains Shareholder Approval for Proposals
SciSparc Ltd. Reschedules Annual General Meeting
SciSparc Secures FDA Approval to Launch Phase IIB Trial for TS Treatment
SciSparc Secures FDA Green Light to US Launch of Its Pivotal Phase IIb Clinical Trial for Breakthrough Tourette Syndrome Treatment
No Data
No Data